Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Koenig

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Pharmacotherapy|July 1, 2024
Evolving resistance landscape in gram-negative pathogens: An update on β-lactam and β-lactam-inhibitor treatment combinations for carbapenem-resistant organismsChristina Koenig, Joseph L Kuti
Ultramicroscopy|June 14, 2025
Measurement of electron beam induced sample heating in SEM experimentsChristina Koenig, Alice Bastos da Silva Fanta, Joerg R Jinschek
The Journal of Antimicrobial Chemotherapy|August 12, 2025
In vivo activity of ceftibuten-ledaborbactam oral combination against serine-β-lactamase-producing Enterobacterales: an assessment in the pyelonephritis and cystitis murine modelChristina Koenig, Fan Yi, David P Nicolau, et al.
The Journal of Antimicrobial Chemotherapy|May 30, 2025
An ex vivo model to determine transmembrane clearance of antimicrobials during continuous renal replacement therapyCole McGrath, Christina Koenig, Hanna F Roenfanz, et al.
International Journal of Antimicrobial Agents|February 19, 2025
Cefiderocol pharmacokinetics in critically-ill patients receiving extra-corporeal membrane oxygenation (ECMO)Christina Koenig, Andrew J Fratoni, Yasmeen Abouelhassan, et al.
The Journal of Antimicrobial Chemotherapy|June 27, 2025
Clinical validation of antimicrobial dosing regimens for continuous renal replacement therapy based on an ex vivo dosing algorithmChristina Koenig, Cole P McGrath, Hanna F Roenfanz, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|March 21, 2025
[S1 guideline: diagnosis and treatment of invasive pulmonary aspergillosis in critically ill/intensive care patients]Dominic Wichmann, Martin Hoenigl, Philipp Koehler, et al.
Infection|June 4, 2025
Diagnosis and treatment of invasive pulmonary aspergillosis in critically ill intensive care patients: executive summary of the German national guideline (AWMF 113-005)Dominic Wichmann, Martin Hoenigl, Philipp Koehler, et al.
Antimicrobial Agents and Chemotherapy|December 10, 2024
Cefiderocol pharmacokinetics during acute pulmonary exacerbations in hospitalized adult persons with cystic fibrosisChristina Koenig, Marguerite L Monogue, Ryan K Shields, et al.
International Journal of Antimicrobial Agents|March 13, 2018
Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapyCaleb J P Economou, Jan T Kielstein, David Czock, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Pharmacotherapy|July 1, 2024
Evolving resistance landscape in gram-negative pathogens: An update on β-lactam and β-lactam-inhibitor treatment combinations for carbapenem-resistant organismsChristina Koenig, Joseph L Kuti
Ultramicroscopy|June 14, 2025
Measurement of electron beam induced sample heating in SEM experimentsChristina Koenig, Alice Bastos da Silva Fanta, Joerg R Jinschek
The Journal of Antimicrobial Chemotherapy|August 12, 2025
In vivo activity of ceftibuten-ledaborbactam oral combination against serine-β-lactamase-producing Enterobacterales: an assessment in the pyelonephritis and cystitis murine modelChristina Koenig, Fan Yi, David P Nicolau, et al.
The Journal of Antimicrobial Chemotherapy|May 30, 2025
An ex vivo model to determine transmembrane clearance of antimicrobials during continuous renal replacement therapyCole McGrath, Christina Koenig, Hanna F Roenfanz, et al.
International Journal of Antimicrobial Agents|February 19, 2025
Cefiderocol pharmacokinetics in critically-ill patients receiving extra-corporeal membrane oxygenation (ECMO)Christina Koenig, Andrew J Fratoni, Yasmeen Abouelhassan, et al.
The Journal of Antimicrobial Chemotherapy|June 27, 2025
Clinical validation of antimicrobial dosing regimens for continuous renal replacement therapy based on an ex vivo dosing algorithmChristina Koenig, Cole P McGrath, Hanna F Roenfanz, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|March 21, 2025
[S1 guideline: diagnosis and treatment of invasive pulmonary aspergillosis in critically ill/intensive care patients]Dominic Wichmann, Martin Hoenigl, Philipp Koehler, et al.
Infection|June 4, 2025
Diagnosis and treatment of invasive pulmonary aspergillosis in critically ill intensive care patients: executive summary of the German national guideline (AWMF 113-005)Dominic Wichmann, Martin Hoenigl, Philipp Koehler, et al.
Antimicrobial Agents and Chemotherapy|December 10, 2024
Cefiderocol pharmacokinetics during acute pulmonary exacerbations in hospitalized adult persons with cystic fibrosisChristina Koenig, Marguerite L Monogue, Ryan K Shields, et al.
International Journal of Antimicrobial Agents|March 13, 2018
Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapyCaleb J P Economou, Jan T Kielstein, David Czock, et al.
Pageof 2